|
Re: No news
|
3
|
Resverlogix Corp.
|
Sep 16, 2022 03:22PM
|
|
Re: Here is the example of the danger of the COVID trial to RVX...
|
3
|
Resverlogix Corp.
|
Nov 12, 2021 02:20AM
|
|
A Special Meeting of Shareholders?
|
3
|
Resverlogix Corp.
|
May 28, 2024 08:57PM
|
|
Re: Expecting a big week.......
|
3
|
Resverlogix Corp.
|
Sep 14, 2015 08:50AM
|
|
Re: RVX is warming up!
|
3
|
Resverlogix Corp.
|
Jan 25, 2022 02:29PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
3
|
Zenith Epigenetics
|
May 19, 2024 10:21PM
|
|
Re: Resverlogix has been shortlisted for the Buzz of Bio award "Pipelines of Promise...
|
3
|
Resverlogix Corp.
|
Apr 04, 2017 09:23AM
|
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
3
|
Resverlogix Corp.
|
Jan 22, 2016 06:31PM
|
|
Re: Zenith Updates
|
3
|
Zenith Epigenetics
|
Feb 03, 2016 11:09AM
|
|
RVX/Zenith accounting for Royalty Preferred Shares Dividends
|
3
|
Zenith Epigenetics
|
Jan 30, 2016 12:43PM
|
|
Re: Protecting shares from being borrowed by shorts
|
3
|
Resverlogix Corp.
|
May 18, 2018 12:19PM
|
|
Re: A Homecoming of Sorts...book value question
|
3
|
Resverlogix Corp.
|
Sep 21, 2015 09:45AM
|
|
Re: Interesting, Foggy Days
|
3
|
Resverlogix Corp.
|
Dec 30, 2016 10:07AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
3
|
Resverlogix Corp.
|
Feb 17, 2022 12:24PM
|
|
Re: Venting Friday!
|
3
|
Resverlogix Corp.
|
Feb 28, 2022 02:55PM
|
|
Re: Thank you to those who voted
|
3
|
Resverlogix Corp.
|
Apr 11, 2017 07:52PM
|
|
Re: A Homecoming of Sorts...book value question
|
3
|
Resverlogix Corp.
|
Sep 21, 2015 10:49AM
|
|
Re: Vote reminder
|
3
|
Zenith Epigenetics
|
Oct 24, 2023 10:22AM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
3
|
Resverlogix Corp.
|
Mar 25, 2022 07:17PM
|
|
Re: US Greenbacks versus our Northern Peso.....
|
3
|
Resverlogix Corp.
|
Feb 04, 2016 04:44PM
|
